Core Viewpoint - The U.S. Department of Justice has filed a False Claims Act complaint against SelectQuote and other health insurance companies, alleging illegal kickbacks related to Medicare Advantage plans, leading to a significant drop in SelectQuote's stock price [2]. Group 1: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against SelectQuote on behalf of its stockholders for possible violations of federal securities laws and unlawful business practices [1]. - The DOJ's complaint alleges that from 2016 to at least 2021, SelectQuote and other insurers paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [2]. Group 2: Stock Market Impact - Following the announcement of the DOJ lawsuit, SelectQuote's stock price decreased by $0.61 per share, representing a 19.24% decline, closing at $2.56 per share on May 1, 2025 [2].

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether SelectQuote and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On May 1 ...

SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving SelectQuote, Inc. (NYSE: SLQT) focused on whether SelectQuote and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the SelectQuote investigation or if you are a SelectQuote investor who suffered a loss and would like to learn mo ...

SelectQuote, Inc. (NYSE: SLQT ) is an interesting company operating in the insurance and healthcare distribution industry, but its business is not very profitable and the expected improvements ahead are not game changers for long-term investors. With the fiscalLabutes IR is a Fund Manager/Analyst specialized in the financial sector, with more than 18 years of experience in the financial markets. I have worked at several type of institutions in the industry, always at the buy side and related to portfolio ma ...

SelectQuote (SLQT) closed the last trading session at $5.49, gaining 23.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $7.33 indicates a 33.5% upside potential.The average comprises three short-term price targets ranging from a low of $7 to a high of $8, with a standard deviation of $0.58. While the lowest estimate indicates an increase of 27.5% from the current price level, th ...

SelectQuote, Inc. (NYSE:SLQT) Q2 2025 Results Conference Call February 10, 2025 5:00 PM ET Company Participants Matt Gunter - Investor Relations Tim Danker - Chief Executive Officer Ryan Clement - Chief Financial Officer Bob Grant - President Conference Call Participants Benjamin Hendrix - RBC Capital Markets George Sutton - Craig Hallum Pat McCann - NOBLE Capital Markets Operator Good afternoon, ladies and gentlemen, and thank you for standing by. My name is Kelvin, and I will be your conference operator t ...

SelectQuote (SLQT) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 233.33%. A quarter ago, it was expected that this company would post a loss of $0.18 per share when it actually produced a loss of $0.26, delivering a surprise of -44.44%.Over the last four quarters, the company has su ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-39295 (Commission File Number) SelectQuote, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3339273 (State or other j ...

Exhibit 10.5 TWELFTH AMENDMENT TO CREDIT AGREEMENT THIS TWELFTH AMENDMENT TO CREDIT AGREEMENT (this "Agreement") is entered into as of February 10, 2025, by and among SELECTQUOTE, INC., a Delaware corporation, as the Borrower, the other Credit Parties party hereto, the Twelfth Amendment Consenting Lenders (as defined below), ARES CAPITAL CORPORATION, as the administrative agent (in such capacity, the "Administrative Agent"), and UMB BANK, N.A., as the revolver agent (in such capacity, the "Revolver Agent"). ...

SelectQuote, Inc. (NYSE:SLQT) Q1 2025 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Matt Gunter - Investor Relations Tim Danker - Chief Executive Officer Ryan Clement - Chief Financial Officer Bob Grant - President Bill Grant - Chief Operating Officer Conference Call Participants Ben Hendrix - RBC Capital Markets George Sutton - Craig-Hallum Pat McCann - NOBLE Capital Markets Operator Welcome to SelectQuote's First Quarter Earnings [Technical Difficulty]. All lines have been plac ...